Back to Results
First PageMeta Content
Accountancy / Business / Fundamental analysis / Valuation / Earnings before interest / taxes / depreciation and amortization / Private equity / Motilal Oswal Group / EV/EBITDA / Cadila Healthcare / Finance / Generally Accepted Accounting Principles / Financial ratios


CDHMOSL-RU-8PG.p65
Add to Reading List

Document Date: 2013-02-12 01:48:25

Open Document

File Size: 220,47 KB

Share Result on Facebook

City

Mumbai / /

Company

Motilal Oswal Securities International Private Limited. / INR2 / Motilal Oswal Capital Markets Singapore Pte Limited / Singapore Motilal Oswal Capital Markets Singapore Pte Limited / Hospira / Cadila Healthcare No No No No / Cadila Healthcare Cadila Healthcare / Formulations APIs Consumer & Others Export / U.S. Motilal Oswal Securities Limited / S&P / Bloomberg / Altana / Biochem Pharma / Motilal Oswal Securities Limited / /

Continent

Europe / /

Country

France / Japan / United States / Brazil / United Kingdom / Singapore / Mexico / India / /

Currency

USD / INR / /

/

Event

Earnings Guidance / M&A / FDA Phase / Business Partnership / /

Facility

Moraiya facility / Moraiya plant / /

IndustryTerm

low-competition products / registered broker / investment services / topical products / chemical entities / technology businesses / /

Organization

Federal Aviation Administration / FDA / U.S. Securities and Exchange Commission / NASD / FINRA / /

Position

registered broker / exempt financial advisor / independent financial advisor / product approvals going forward / research analyst / Financial Advisors Regulations / growth driver / registered investment adviser / Analyst / Major Institutional Investors / dealer / /

Product

INR100m / /

Technology

CMP / /

SocialTag